DANIEL M JUNIUS Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DANIEL M JUNIUS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DANIEL M JUNIUS. DANIEL M JUNIUS is Director in IDEXX LABORATORIES INC /DE ($IDXX) and Chief Executive Officer in IMMUNOGEN INC ($IMGN) and Director in IMMUNOGEN INC ($IMGN) and Director in Vitae Pharmaceuticals, Inc ($VTAE) and Director in GLYCOMIMETICS INC ($GLYC).
Latest Insider Trading Transactions of DANIEL M JUNIUS
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, GLYC, IDXX, IMGN, VTAE
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 14 2021 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Option Exercise | A | 512.31 | 723 | 370,400 | 723 | |
| May 14 2021 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Option Exercise | A | 0.00 | 224 | 0 | 3,387 | |
| May 04 2021 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Grant | A | 548.99 | 11 | 6,039 | 2,886 | 2.9 K to 2.9 K (+0.38 %) |
| Feb 24 2021 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Option Exercise | M | 85.00 | 1,000 | 85,000 | 4,902 | |
| Feb 24 2021 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Option Exercise | M | 79.54 | 898 | 71,427 | 0 | |
| Feb 24 2021 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Sell | S | 538.57 | 1,888 | 1,016,815 | 2,875 | 4.8 K to 2.9 K (-39.64 %) |
| Feb 24 2021 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Sell | S | 539.19 | 10 | 5,392 | 4,763 | 4.8 K to 4.8 K (-0.21 %) |
| Feb 24 2021 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Buy | M | 85.00 | 1,000 | 85,000 | 4,773 | 3.8 K to 4.8 K (+26.50 %) |
| Feb 24 2021 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Buy | M | 79.54 | 898 | 71,427 | 3,773 | 2.9 K to 3.8 K (+31.23 %) |
| Feb 03 2021 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Grant | A | 478.68 | 13 | 6,223 | 2,875 | 2.9 K to 2.9 K (+0.45 %) |
| Nov 02 2020 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Grant | A | 424.82 | 15 | 6,372 | 2,862 | 2.8 K to 2.9 K (+0.53 %) |
| Aug 21 2020 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Option Exercise | M | 63.95 | 3,722 | 238,022 | 0 | |
| Aug 21 2020 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Sell | S | 382.61 | 3,722 | 1,424,063 | 2,847 | 6.6 K to 2.8 K (-56.66 %) |
| Aug 21 2020 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Buy | M | 63.95 | 3,722 | 238,022 | 6,569 | 2.8 K to 6.6 K (+130.73 %) |
| Aug 03 2020 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Grant | A | 371.10 | 13 | 4,824 | 2,847 | 2.8 K to 2.8 K (+0.46 %) |
| May 27 2020 | GLYC | GLYCOMIMETICS INC | JUNIUS DANIEL M | Director | Option Exercise | A | 3.00 | 21,000 | 63,000 | 21,000 | |
| May 20 2020 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Option Exercise | M | 63.95 | 4,000 | 255,800 | 3,422 | |
| May 20 2020 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Buy | S | 295.61 | 4,000 | 1,182,433 | 2,834 | -1,166 to 2.8 K (-343.05 %) |
| May 20 2020 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Buy | M | 63.95 | 4,000 | 255,800 | 6,834 | 2.8 K to 6.8 K (+141.14 %) |
| May 08 2020 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Option Exercise | A | 283.59 | 1,279 | 362,712 | 1,279 | |
| May 08 2020 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Option Exercise | A | 0.00 | 370 | 0 | 3,163 | |
| Mar 10 2020 | GLYC | GLYCOMIMETICS INC | JUNIUS DANIEL M | Director | Buy | P | 3.40 | 20,000 | 68,000 | 38,000 | 18 K to 38 K (+111.11 %) |
| Oct 31 2019 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Grant | A | 273.85 | 23 | 6,299 | 2,812 | 2.8 K to 2.8 K (+0.82 %) |
| Aug 15 2019 | GLYC | GLYCOMIMETICS INC | JUNIUS DANIEL M | Director | Buy | P | 3.18 | 10,000 | 31,800 | 18,000 | 8 K to 18 K (+125.00 %) |
| Aug 15 2019 | GLYC | GLYCOMIMETICS INC | JUNIUS DANIEL M | Director | Buy | P | 3.18 | 10,000 | 31,800 | 18,000 | 8 K to 18 K (+125.00 %) |
| Aug 01 2019 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Grant | A | 286.05 | 22 | 6,293 | 2,789 | 2.8 K to 2.8 K (+0.80 %) |
| May 21 2019 | GLYC | GLYCOMIMETICS INC | JUNIUS DANIEL M | Director | Option Exercise | A | 12.39 | 21,000 | 260,190 | 21,000 | |
| May 10 2019 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Option Exercise | A | 245.79 | 1,404 | 345,089 | 1,404 | |
| May 10 2019 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Option Exercise | A | 0.00 | 427 | 0 | 2,793 | |
| May 02 2019 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Grant | A | 232.00 | 26 | 6,032 | 2,767 | 2.7 K to 2.8 K (+0.95 %) |
| Feb 01 2019 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Grant | A | 207.68 | 29 | 6,023 | 2,741 | 2.7 K to 2.7 K (+1.07 %) |
| Nov 01 2018 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Grant | A | 210.22 | 28 | 5,886 | 2,712 | 2.7 K to 2.7 K (+1.04 %) |
| Aug 01 2018 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Grant | A | 237.76 | 25 | 5,944 | 2,684 | 2.7 K to 2.7 K (+0.94 %) |
| May 11 2018 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Option Exercise | A | 206.62 | 2,187 | 451,878 | 2,187 | |
| May 11 2018 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Option Exercise | A | 0.00 | 224 | 0 | 2,366 | |
| May 02 2018 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Grant | A | 194.49 | 31 | 6,029 | 2,659 | 2.6 K to 2.7 K (+1.18 %) |
| Mar 16 2018 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Director | Option Exercise | M | 4.29 | 25,000 | 107,250 | 113,518 | |
| Mar 16 2018 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Director | Sell | S | 12.02 | 25,000 | 300,405 | 184,987 | 210 K to 185 K (-11.91 %) |
| Mar 16 2018 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Director | Buy | M | 4.29 | 25,000 | 107,250 | 209,987 | 185 K to 210 K (+13.51 %) |
| Feb 23 2018 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Director | Sell | S | 12.00 | 11,713 | 140,556 | 184,987 | 196.7 K to 185 K (-5.95 %) |
| Feb 21 2018 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Director | Sell | S | 11.68 | 25,000 | 292,000 | 196,700 | 221.7 K to 196.7 K (-11.28 %) |
| Feb 21 2018 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Director | Sell | S | 11.68 | 25,000 | 292,000 | 196,700 | 221.7 K to 196.7 K (-11.28 %) |
| Feb 20 2018 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Director | Option Exercise | M | 4.29 | 25,000 | 107,250 | 163,518 | |
| Feb 20 2018 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Director | Buy | M | 4.29 | 25,000 | 107,250 | 221,700 | 196.7 K to 221.7 K (+12.71 %) |
| Feb 14 2018 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Director | Option Exercise | M | 3.30 | 46,667 | 154,001 | 0 | |
| Feb 14 2018 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Director | Sell | S | 10.01 | 46,667 | 467,253 | 196,700 | 243.4 K to 196.7 K (-19.18 %) |
| Feb 14 2018 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Director | Buy | M | 3.30 | 46,667 | 154,001 | 243,367 | 196.7 K to 243.4 K (+23.72 %) |
| Feb 01 2018 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Grant | A | 186.59 | 32 | 5,971 | 2,628 | 2.6 K to 2.6 K (+1.23 %) |
| Nov 01 2017 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Grant | A | 164.41 | 36 | 5,919 | 2,596 | 2.6 K to 2.6 K (+1.41 %) |
| Jul 31 2017 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Grant | A | 167.52 | 35 | 5,863 | 2,560 | 2.5 K to 2.6 K (+1.39 %) |
| Jun 16 2017 | GLYC | GLYCOMIMETICS INC | JUNIUS DANIEL M | Director | Grant | A | 11.27 | 3,000 | 33,810 | 8,000 | 5 K to 8 K (+60.00 %) |
| Jun 15 2017 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Director | Option Exercise | A | 4.64 | 10,000 | 46,400 | 10,000 | |
| Jun 15 2017 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Director | Option Exercise | A | 0.00 | 3,000 | 0 | 4,500 | |
| May 30 2017 | GLYC | GLYCOMIMETICS INC | JUNIUS DANIEL M | Director | Option Exercise | A | 13.89 | 11,000 | 152,790 | 11,000 | |
| May 05 2017 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Option Exercise | A | 160.28 | 3,046 | 488,213 | 3,046 | |
| May 05 2017 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Option Exercise | A | 0.00 | 289 | 0 | 2,142 | |
| May 01 2017 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Grant | A | 167.73 | 30 | 5,032 | 2,525 | 2.5 K to 2.5 K (+1.20 %) |
| Feb 09 2017 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Option Exercise | M | 64.69 | 3,000 | 194,070 | 2,964 | |
| Feb 09 2017 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Sell | S | 141.76 | 3,000 | 425,264 | 2,495 | 5.5 K to 2.5 K (-54.60 %) |
| Feb 09 2017 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Buy | M | 64.69 | 3,000 | 194,070 | 5,495 | 2.5 K to 5.5 K (+120.24 %) |
| Jan 31 2017 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Grant | A | 120.50 | 41 | 4,941 | 2,495 | 2.5 K to 2.5 K (+1.67 %) |
| Dec 21 2016 | GLYC | GLYCOMIMETICS INC | JUNIUS DANIEL M | Director | Buy | P | 6.01 | 5,000 | 30,050 | 5,000 | 0 to 5 K |
| Dec 13 2016 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Director | Option Exercise | A | 1.84 | 5,000 | 9,200 | 5,000 | |
| Dec 13 2016 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Director | Option Exercise | A | 0.00 | 1,500 | 0 | 1,500 | |
| Oct 31 2016 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Grant | A | 105.05 | 48 | 5,042 | 2,454 | 2.4 K to 2.5 K (+2.00 %) |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | JUNIUS DANIEL M | Director | Option Exercise | D | 11.37 | 20,000 | 227,400 | 0 | |
| Aug 02 2016 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Grant | A | 93.79 | 53 | 4,971 | 2,406 | 2.4 K to 2.4 K (+2.25 %) |
| Jul 27 2016 | VTAE | Vitae Pharmaceutic ... | JUNIUS DANIEL M | Director | Option Exercise | A | 11.37 | 20,000 | 227,400 | 20,000 | |
| Jun 02 2016 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Director | Option Exercise | M | 3.19 | 27,085 | 86,401 | 0 | |
| Jun 02 2016 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Director | Buy | M | 3.19 | 27,085 | 86,401 | 196,700 | 169.6 K to 196.7 K (+15.97 %) |
| May 19 2016 | GLYC | GLYCOMIMETICS INC | JUNIUS DANIEL M | Director | Option Exercise | A | 6.35 | 11,000 | 69,850 | 11,000 | |
| May 06 2016 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Option Exercise | A | 85.00 | 5,902 | 501,670 | 5,902 | |
| May 06 2016 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Option Exercise | A | 0.00 | 515 | 0 | 1,853 | |
| May 03 2016 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Grant | A | 84.35 | 59 | 4,977 | 2,353 | 2.3 K to 2.4 K (+2.57 %) |
| Mar 21 2016 | GLYC | GLYCOMIMETICS INC | JUNIUS DANIEL M | Director | Option Exercise | A | 5.99 | 22,000 | 131,780 | 22,000 | |
| Feb 02 2016 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Grant | A | 70.14 | 71 | 4,980 | 2,294 | 2.2 K to 2.3 K (+3.19 %) |
| Jan 04 2016 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Chief Executive Off ... | Option Exercise | M | 3.19 | 5,416 | 17,277 | 27,085 | |
| Jan 04 2016 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Chief Executive Off ... | Sell | S | 13.17 | 5,416 | 71,349 | 169,615 | 175 K to 169.6 K (-3.09 %) |
| Jan 04 2016 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Chief Executive Off ... | Buy | M | 3.19 | 5,416 | 17,277 | 175,031 | 169.6 K to 175 K (+3.19 %) |
| Dec 21 2015 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Chief Executive Off ... | Gift | G | 0.00 | 1,003 | 0 | 169,615 | 170.6 K to 169.6 K (-0.59 %) |
| Dec 01 2015 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Chief Executive Off ... | Option Exercise | M | 3.19 | 5,416 | 17,277 | 32,501 | |
| Dec 01 2015 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Chief Executive Off ... | Sell | S | 13.11 | 5,416 | 71,025 | 170,618 | 176 K to 170.6 K (-3.08 %) |
| Dec 01 2015 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Chief Executive Off ... | Buy | M | 3.19 | 5,416 | 17,277 | 176,035 | 170.6 K to 176 K (+3.17 %) |
| Nov 04 2015 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Chief Executive Off ... | Option Exercise | M | 4.29 | 5,907 | 25,341 | 188,518 | |
| Nov 04 2015 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Chief Executive Off ... | Buy | M | 4.29 | 5,907 | 25,341 | 170,618 | 164.7 K to 170.6 K (+3.59 %) |
| Nov 03 2015 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Grant | A | 68.62 | 73 | 5,009 | 2,223 | 2.2 K to 2.2 K (+3.40 %) |
| Nov 03 2015 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Chief Executive Off ... | Option Exercise | M | 3.19 | 5,497 | 17,535 | 37,917 | |
| Nov 03 2015 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Chief Executive Off ... | Option Exercise | M | 5.77 | 122 | 704 | 62,669 | |
| Nov 03 2015 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Chief Executive Off ... | Option Exercise | M | 4.29 | 5,575 | 23,917 | 194,425 | |
| Nov 03 2015 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Chief Executive Off ... | Sell | S | 12.00 | 5,497 | 65,964 | 159,812 | 165.3 K to 159.8 K (-3.33 %) |
| Nov 03 2015 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Chief Executive Off ... | Buy | M | 3.19 | 5,497 | 17,535 | 165,309 | 159.8 K to 165.3 K (+3.44 %) |
| Nov 03 2015 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Chief Executive Off ... | Buy | M | 5.77 | 122 | 704 | 159,812 | 159.7 K to 159.8 K (+0.08 %) |
| Nov 03 2015 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Chief Executive Off ... | Buy | M | 4.29 | 5,575 | 23,917 | 159,690 | 154.1 K to 159.7 K (+3.62 %) |
| Oct 30 2015 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Chief Executive Off ... | Option Exercise | M | 3.19 | 5,335 | 17,019 | 43,414 | |
| Oct 30 2015 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Chief Executive Off ... | Sell | S | 12.01 | 5,335 | 64,072 | 154,115 | 159.5 K to 154.1 K (-3.35 %) |
| Oct 30 2015 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Chief Executive Off ... | Buy | M | 3.19 | 5,335 | 17,019 | 159,450 | 154.1 K to 159.5 K (+3.46 %) |
| Sep 09 2015 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Chief Executive Off ... | Option Exercise | M | 5.77 | 4,899 | 28,267 | 62,791 | |
| Sep 09 2015 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Chief Executive Off ... | Buy | M | 5.77 | 4,899 | 28,267 | 159,014 | 154.1 K to 159 K (+3.18 %) |
| Sep 01 2015 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Chief Executive Off ... | Option Exercise | M | 3.19 | 5,416 | 17,277 | 48,749 | |
| Sep 01 2015 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Chief Executive Off ... | Sell | S | 13.15 | 5,416 | 71,238 | 154,115 | 159.5 K to 154.1 K (-3.39 %) |
| Sep 01 2015 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Chief Executive Off ... | Buy | M | 3.19 | 5,416 | 17,277 | 159,531 | 154.1 K to 159.5 K (+3.51 %) |
| Aug 18 2015 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Chief Executive Off ... | Option Exercise | M | 5.77 | 12,310 | 71,029 | 67,690 | |
| Aug 18 2015 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Chief Executive Off ... | Buy | M | 5.77 | 12,310 | 71,029 | 154,115 | 141.8 K to 154.1 K (+8.68 %) |
| Aug 05 2015 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Buy | P | 73.15 | 1,000 | 73,150 | 2,150 | 1.2 K to 2.2 K (+86.96 %) |
| Aug 04 2015 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Chief Executive Off ... | Option Exercise | M | 3.19 | 5,416 | 17,277 | 54,165 | |
| Aug 04 2015 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Chief Executive Off ... | Sell | S | 17.03 | 5,416 | 92,247 | 141,805 | 147.2 K to 141.8 K (-3.68 %) |
| Aug 04 2015 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Chief Executive Off ... | Buy | M | 3.19 | 5,416 | 17,277 | 147,221 | 141.8 K to 147.2 K (+3.82 %) |
| Aug 03 2015 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Grant | A | 71.34 | 70 | 4,994 | 1,150 | 1.1 K to 1.2 K (+6.48 %) |
| Jul 14 2015 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Chief Executive Off ... | Option Exercise | A | 16.72 | 205,000 | 3,427,600 | 205,000 | |
| Jul 02 2015 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Chief Executive Off ... | Option Exercise | M | 3.19 | 5,416 | 17,277 | 59,584 | |
| Jul 02 2015 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Chief Executive Off ... | Sell | S | 14.34 | 5,416 | 77,676 | 141,805 | 147.2 K to 141.8 K (-3.68 %) |
| Jul 02 2015 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Chief Executive Off ... | Buy | M | 3.19 | 5,416 | 17,277 | 147,221 | 141.8 K to 147.2 K (+3.82 %) |
| May 11 2015 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Chief Executive Off ... | Option Exercise | M | 5.74 | 1,215 | 6,974 | 0 | |
| May 11 2015 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Chief Executive Off ... | Sell | S | 8.02 | 1,215 | 9,744 | 141,805 | 143 K to 141.8 K (-0.85 %) |
| May 11 2015 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Chief Executive Off ... | Buy | M | 5.74 | 1,215 | 6,974 | 143,020 | 141.8 K to 143 K (+0.86 %) |
| May 08 2015 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Option Exercise | A | 127.90 | 3,861 | 493,822 | 3,861 | |
| May 08 2015 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Option Exercise | A | 0.00 | 342 | 0 | 669 | |
| May 05 2015 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Chief Executive Off ... | Option Exercise | M | 5.74 | 10,647 | 61,114 | 1,215 | |
| May 05 2015 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Chief Executive Off ... | Option Exercise | M | 5.74 | 35,315 | 202,708 | 11,862 | |
| May 05 2015 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Chief Executive Off ... | Buy | M | 5.74 | 10,647 | 61,114 | 141,805 | 131.2 K to 141.8 K (+8.12 %) |
| May 05 2015 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Chief Executive Off ... | Sell | S | 8.36 | 35,315 | 295,198 | 131,158 | 166.5 K to 131.2 K (-21.21 %) |
| May 05 2015 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Chief Executive Off ... | Buy | M | 5.74 | 35,315 | 202,708 | 166,473 | 131.2 K to 166.5 K (+26.93 %) |
| May 04 2015 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Grant | A | 125.37 | 40 | 5,015 | 540 | 500 to 540 (+8.00 %) |
| Apr 22 2015 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Chief Executive Off ... | Option Exercise | M | 5.74 | 6,969 | 40,002 | 47,177 | |
| Apr 22 2015 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Chief Executive Off ... | Buy | M | 5.74 | 6,969 | 40,002 | 131,158 | 124.2 K to 131.2 K (+5.61 %) |
| Apr 06 2015 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Chief Executive Off ... | Option Exercise | M | 5.74 | 26,132 | 149,998 | 54,146 | |
| Apr 06 2015 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Chief Executive Off ... | Buy | M | 5.74 | 26,132 | 149,998 | 124,189 | 98.1 K to 124.2 K (+26.65 %) |
Page: 1